[Effect of fluvastatin and fenofibrate on the antioxidative barrier enzyme activity in patients with dyslipidemia]
Author(s): Kowalski J, Olejniczak J, Blaszczyk J, Blaszczyk-Suszynska J, Kowalski M, Petecka E, Kedziora J
Affiliation(s): Klinika Chorob Pluc WAM w lodzi.
Publication date & source: 2003-04, Pol Merkuriusz Lek., 14(82):285-8.
Publication type: Clinical Trial; Randomized Controlled Trial
The effect of fluvastatin and fenofibrate on antioxidative enzymatic activity in patients with stable angina and mixed hyperlipidaemia was investigated. Thirty-five patients (13 men and 22 women) aged 40-77 years, were randomly divided into two groups. The first group comprised 20 patients who were administered fluvastatin 40 mg once daily at bedtime for 30 days. The second group consisted of 15 patients who were administered fenofibrate 200 mg once daily at bedtime for 30 days. The control group comprised 11 clinically healthy persons aged 21-54 years. The activities of SOD-1, CAT and GSH-Px in erythrocytes were measured. Fluvastatin induced an increase of the activities of all investigated enzymes. Fenofibrate caused no change of enzyme activities in patients with dyslipidaemia.